UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000008599 |
|---|---|
| Receipt number | R000010103 |
| Scientific Title | Preferences for pharmacists' provision of information in patients with breast cancer: Discrete Choice Experiments, Cross-sectional Study |
| Date of disclosure of the study information | 2012/08/06 |
| Last modified on | 2013/04/12 09:43:17 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Preferences for pharmacists' provision of information in patients with breast cancer: Discrete Choice Experiments, Cross-sectional Study
Acronym
Preferences for pharmacists' provision of information in patients with breast cancer
Scientific Title
Preferences for pharmacists' provision of information in patients with breast cancer: Discrete Choice Experiments, Cross-sectional Study
Scientific Title:Acronym
Preferences for pharmacists' provision of information in patients with breast cancer
Region
| Japan |
Condition
Condition
breast cancer
Classification by specialty
| Breast surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To explore patients' preferences for pharmacists's provsion of information among patients with breast cancer.
Basic objectives2
Others
Basic objectives -Others
Tendency of patients' preference
Trial characteristics_1
Exploratory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
Patients' preference
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Female
Key inclusion criteria
1. 20 years and older
2. Diagnosed as breast cancer
3. Outpatients have previously received or is currently receiving chemothera
Key exclusion criteria
1. ECOG PS 3-4
2. Cognitive disorder, agitation or delirium
3. Severe psychiatric disorder
4. Patients judged inappropriate for this study by the health care provider
Target sample size
280
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Takao Akashi |
Organization
Tokyo Medical University Hospital
Division name
Department of Pharmacy
Zip code
Address
160-0022, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, Japan
TEL
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Takashi Kawaguchi |
Organization
Tokyo University of Pharmacy and Life Sciences
Division name
Department of Practical Pharmacy
Zip code
Address
192-0392, 1432-1 Horinouchi, Hachioji, Tokyo, Japan
TEL
Homepage URL
Sponsor or person
Institute
Tokyo University of Pharmacy and Life Sciences
Department of Practical Pharamcy
Institute
Department
Personal name
Funding Source
Organization
Tokyo Medical University Hospital
Department of Pharamcy
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Nagumo Clinic
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
東京医科大学病院（東京都）、ナグモクリニック（東京都）
Other administrative information
Date of disclosure of the study information
| 2012 | Year | 08 | Month | 06 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2012 | Year | 08 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2012 | Year | 08 | Month | 06 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Two types of questionnaire were randomly assigned to patients. Patients were asked to complete the questionnaire based discrete choice experiments one time.
Management information
Registered date
| 2012 | Year | 08 | Month | 02 | Day |
Last modified on
| 2013 | Year | 04 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010103
